MPO and peripheral arterial disease: Our recent study also indicated that SCT decreased plasma myeloperoxidase level in PAD (Lin et al., 2021) to protect erythrocytes against oxidative damage and consequently improved the rheological function in people with PAD (Koutakis et al., 2018).